angiotensin ii has been researched along with Extramembranous Glomerulopathy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Qiu, D; Wang, M; Zhao, N | 1 |
| Hu, Y; Liu, D; Liu, F; Liu, Z; Pan, S; Qiao, Y; Tian, F; Wang, X; Yang, Y; Zhang, Y | 1 |
| Chen, Y; Huang, WW; Jin, LW; Pan, M; Xu, XY; Ye, HY; Zheng, SB; Zheng, Y | 1 |
| Lu, GY; Sha, WG; Shen, L; Xu, DY; Zhou, L | 1 |
| Lee, HS | 1 |
| Ardiles, LG; Aros, CA; Burgos, ME; Carpio, D; Droguett, A; Egido, J; Flores, CA; Mezzano, SA; Ruiz-Ortega, M; Vío, CP | 1 |
| Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M | 1 |
| Baumelou, A; Bletry, O; Deray, G; Faucher, C; Godeau, P; Jacobs, C; Rieu, P | 1 |
| Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C | 1 |
| Miyauchi, N; Nakamura, Y | 1 |
| Miettinen, A; Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
1 review(s) available for angiotensin ii and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Pathogenic role of TGF-β in the progression of podocyte diseases.
Topics: Angiotensin II; Animals; Biomechanical Phenomena; Connective Tissue Growth Factor; Denys-Drash Syndrome; Diabetic Nephropathies; Glomerular Basement Membrane; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Kidney Diseases; Models, Biological; Paracrine Communication; Podocytes; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
10 other study(ies) available for angiotensin ii and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Knockdown of circ_CDYL Contributes to Inhibit Angiotensin II-Induced Podocytes Apoptosis in Membranous Nephropathy via the miR-149-5p/TNFSF11 Pathway.
Topics: Angiotensin II; Apoptosis; Co-Repressor Proteins; Factor XI; Glomerulonephritis, Membranous; Humans; Hydro-Lyases; MicroRNAs; Podocytes; RANK Ligand | 2022 |
MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor.
Topics: Angiotensin II; Animals; Antagomirs; Apoptosis; Case-Control Studies; Cell Line; Disease Models, Animal; Female; Glomerulonephritis, Membranous; Humans; Mice, Inbred BALB C; MicroRNAs; Podocytes; Receptors, Phospholipase A2; Signal Transduction | 2018 |
Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway.
Topics: Adult; Aged; Angiotensin II; Apoptosis; Down-Regulation; Female; Glomerulonephritis, Membranous; Humans; Kidney; Male; MicroRNAs; Middle Aged; Podocytes; RNA, Long Noncoding; Signal Transduction; Toll-Like Receptor 4; Up-Regulation | 2019 |
Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy.
Topics: 3' Untranslated Regions; Angiotensin II; Apoptosis; Binding Sites; Case-Control Studies; Caspase 3; Cell Line; Down-Regulation; Glomerulonephritis, Membranous; Humans; MicroRNAs; Podocytes; Receptors, Purinergic P2X7; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Transfection | 2015 |
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy.
Topics: Angiotensin II; Becaplermin; Fibroblasts; Glomerulonephritis, Membranous; Humans; Kidney; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Renin-Angiotensin System; Transforming Growth Factor beta; Up-Regulation | 2003 |
The CARI guidelines. Prevention of progression of kidney disease.
Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy | 2006 |
Medical nephrectomy with CsA and angiotensin II in a case of life-threatening membranous glomerulonephritis.
Topics: Adult; Angiotensin II; Cyclosporine; Glomerulonephritis, Membranous; Humans; Kidney; Male; Nephrectomy; Nephrotic Syndrome | 1994 |
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta | 1997 |
Antiproteinuric effect of an angiotensin II receptor antagonist in membranous nephropathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Glomerulonephritis, Membranous; Humans; Kidney; Male; Middle Aged; Proteinuria | 2001 |
Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Body Weight; Captopril; Drinking; Enzyme Inhibitors; Female; Glomerulonephritis; Glomerulonephritis, Membranous; Imidazoles; Kidney; Kidney Failure, Chronic; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles | 2002 |